Skip to main content

SciBite - Open Intelligence on Pharmaceutical Discovery & Development

Lee Harland, is a visitor in the ChEMBL group here at EMBL-EBI, and he is collaborating with us on semantic web data integration, text-mining, target ontologies and so forth. I asked him to write a small piece for the ChEMBL-og on one of his personal projects - SciBites, and here is what he wrote......

"SciBite is a new biomedical alerting service tailored to pharmaceutically relevant questions and focused on targets, diseases and drugs. The premise is simple, right now if you're a scientist interested in say, Asthma, how can you stay on top of all the lastest developments? You can of course, set up pubmed searches, patent searches, google news searches (making sure you have remembered every possible synonym as these tools won't do that for you). What you'll get back is a stream of articles. Some relevant, many not, and you'll have to read them to actually find out. We thought there had to be a better way.. What we really wanted was a kind of Twitter for "things", where the drugs, disease and targets could each tweet relevant news, in an easily consumable (and discoverable) way. So we built SciBite.

SciBite works by continually scanning 1000s of sources including literature, patents, news feeds, blogs, databases and more. It looks at every new article and automatically tags the targets, diseases, drugs, companies and 'contexts' (such as "biomaker study", "regulatory approval", "animal model" etc), that it finds. Users can then go to the website and view information by topic, not by source. The lists can be filtered based on source or other criteria such as regulatory approval or biomarkers. Everything is available as an RSS feed so users can stay on top of latest news. Information is presented in a very visual way, making it really easy to scan new articles and identify the key topics. We also have relevancy filters to remove spurious and irrelevant news (although this will never be perfect!). Finally, our "related topics" function allows you to quickly find the targets, diseases or drugs being co-mentioned with the thing you're interested in, which is an incredibly powerful way to spot new and interesting connections.

There are a number of major content companies doing this sort of thing, and as a small (tiny) company, we cannot hope to match their levels of curation and resources. However, we believe that this sort of information should be available to everyone and so we hope that by using technology we can provide something that comes close to what the major players offer. We decided early on that as we were using a lot of public data (including ChEMBL), the site itself should be free and support these efforts. We're also making all our data and APIs freely available to any non-profit organisation expressing an interest. 

We've seen a great growth in user numbers since our very low-key launch at the start of February. Over 2000 people have used the site, and we've done hardly any advertising... Its daunting to see that many so soon, but its a great feeling to know people are finding it useful! What's there now is really just the start. The aim was to build a platform that connected news to things, which we've done. The next stages are to do much more with the data. This is one of the things I'll be exploring as part of my Visitorship with the ChEMBL group, we're looking at some interesting company-centric profiling, tracking whats going on with each organisations drugs. There's a whole lot more planned for 2012 too!

Anyone interested can use the system for free now, at I tweet as @SciBitely and our blog is at"

Wow! Look at what is there.


Popular posts from this blog

UniChem 2.0

UniChem new beta interface and web services We are excited to announce that our UniChem beta site will become the default one on the 11th of May. The new system will allow us to better maintain UniChem and to bring new functionality in a more sustainable way. The current interface and web services will still be reachable for a period of time at . In addition to it, the most popular legacy REST endpoints will also remain implemented in the new web services: Some downtime is expected during the swap.  What's new? UniChem’s current API and web application is implemented with a framework version that’s not maintained and the cost of updating it surpasses the cost of rebuilding it. In order to improve stability, security, and support the implementation and fast delivery of new features, we have decided to revamp our user-facing systems using the latest version of widely used and maintained frameworks, i

A python client for accessing ChEMBL web services

Motivation The CheMBL Web Services provide simple reliable programmatic access to the data stored in ChEMBL database. RESTful API approaches are quite easy to master in most languages but still require writing a few lines of code. Additionally, it can be a challenging task to write a nontrivial application using REST without any examples. These factors were the motivation for us to write a small client library for accessing web services from Python. Why Python? We choose this language because Python has become extremely popular (and still growing in use) in scientific applications; there are several Open Source chemical toolkits available in this language, and so the wealth of ChEMBL resources and functionality of those toolkits can be easily combined. Moreover, Python is a very web-friendly language and we wanted to show how easy complex resource acquisition can be expressed in Python. Reinventing the wheel? There are already some libraries providing access to ChEMBL d

ChEMBL 30 released

  We are pleased to announce the release of ChEMBL 30. This version of the database, prepared on 22/02/2022 contains: 2,786,911 compound records 2,157,379 compounds (of which 2,136,187 have mol files) 19,286,751 activities 1,458,215 assays 14,855 targets 84,092 documents Data can be downloaded from the ChEMBL FTP site: Please see ChEMBL_30 release notes for full details of all changes in this release: New Deposited Datasets EUbOPEN Chemogenomic Library (src_id = 55, ChEMBL Document ID CHEMBL4689842):   The EUbOPEN consortium is an Innovative Medicines Initiative (IMI) funded project to enable and unlock biology in the open. The aims of the project are to assemble an open access chemogenomic library comprising about 5,000 well annotated compounds covering roughly 1,000 different proteins, to synthesize at least

LSH-based similarity search in MongoDB is faster than postgres cartridge.

TL;DR: In his excellent blog post , Matt Swain described the implementation of compound similarity searches in MongoDB . Unfortunately, Matt's approach had suboptimal ( polynomial ) time complexity with respect to decreasing similarity thresholds, which renders unsuitable for production environments. In this article, we improve on the method by enhancing it with Locality Sensitive Hashing algorithm, which significantly reduces query time and outperforms RDKit PostgreSQL cartridge . myChEMBL 21 - NoSQL edition    Given that NoSQL technologies applied to computational chemistry and cheminformatics are gaining traction and popularity, we decided to include a taster in future myChEMBL releases. Two especially appealing technologies are Neo4j and MongoDB . The former is a graph database and the latter is a BSON document storage. We would like to provide IPython notebook -based tutorials explaining how to use this software to deal with common cheminformatics p

Multi-task neural network on ChEMBL with PyTorch 1.0 and RDKit

  Update: KNIME protocol with the model available thanks to Greg Landrum. Update: New code to train the model and ONNX exported trained models available in github . The use and application of multi-task neural networks is growing rapidly in cheminformatics and drug discovery. Examples can be found in the following publications: - Deep Learning as an Opportunity in VirtualScreening - Massively Multitask Networks for Drug Discovery - Beyond the hype: deep neural networks outperform established methods using a ChEMBL bioactivity benchmark set But what is a multi-task neural network? In short, it's a kind of neural network architecture that can optimise multiple classification/regression problems at the same time while taking advantage of their shared description. This blogpost gives a great overview of their architecture. All networks in references above implement the hard parameter sharing approach. So, having a set of activities relating targets and molecules we can tra